A New Clue in Developmental Disorders
Bi-allelic mutations associated with intellectual disability and brain abnormalities
Clinical Scorecard: A New Clue in Developmental Disorders
At a Glance
| Category | Detail |
|---|
| Condition | ASTN1-related neurodevelopmental disorders |
| Key Mechanisms | Bi-allelic variants in the ASTN1 gene disrupt neuronal migration during brain development. |
| Target Population | Individuals with unexplained neurodevelopmental disorders, particularly children. |
| Care Setting | Pediatric and neurological practice. |
Key Highlights
- ASTN1 gene variants linked to developmental delay and intellectual disability.
- Clinical features include autism spectrum disorder, ADHD, and epilepsy.
- Brain imaging shows variable results, from normal to significant abnormalities.
- Importance of comprehensive genomic testing for accurate diagnosis.
- Recognition of complex inheritance patterns in neurodevelopmental disorders.
Guideline-Based Recommendations
Diagnosis
- Consider comprehensive genomic testing for patients with unexplained neurodevelopmental disorders.
Management
- Provide genetic counseling and family risk assessment based on ASTN1 findings.
Monitoring & Follow-up
- Monitor developmental progress and associated clinical features in affected individuals.
Risks
- Potential for structural brain abnormalities and developmental impairment.
Patient & Prescribing Data
Individuals with bi-allelic variants in the ASTN1 gene.
Management strategies should be tailored based on the spectrum of clinical features.
Clinical Best Practices
- Utilize exome or genome sequencing to identify rare variants.
- Consider multilocus pathogenic variation in genetic assessments.
- Recognize the broad clinical spectrum associated with ASTN1-related disorders.
References
